Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome

Autor: Sigrid Brantner-Inthaler, Martin Pritsch, Frank Leypoldt, Astrid Blaschek, Thomas Berger, Markus Raucherzauner, Kathrin Schanda, Georgi Kuchukhidze, Mareike Schimmel, Thaddaeus Gotwald, Katharina Diepold, Michael Karenfort, Christian Lechner, Banu Anlar, Romana Höftberger, Kevin Rostasy, Simone Mader, S. Leiz, Silvia Vieker, Charlotte Thiels, Daniela Pohl, Matthias Baumann, Eva-Maria Hennes, Daniel Tibussek, Andrea Klein, V. Kraus, Barbara Bajer-Kornek, Johannes Koch, Imke Poggenburg, Ursula Gruber-Sedlmayr, Klaus Marquard, Astrid Eisenkölbl, Markus Reindl, Carolin Zeches, Martin Häusler

Publikováno v: Hennes, Eva-Maria; Baumann, Matthias; Schanda, Kathrin; Anlar, Banu; Bajer-Kornek, Barbara; Blaschek, Astrid; Brantner-Inthaler, Sigrid; Diepold, Katharina; Eisenkölbl, Astrid; Gotwald, Thaddäus; Kuchukhidze, Georgi; Gruber-Sedlmayr, Ursula; Häusler, Martin; Höftberger, Romana; Karenfort, Michael; Klein, Andrea; Koch, Johannes; Kraus, Verena; Lechner, Christian; Leiz, Steffen; ... (2017). Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology, 89(9), pp. 900-908. Lippincott Williams & Wilkins 10.1212/WNL.0000000000004312

Objective:To assess the prognostic value of MOG antibodies (abs) in the differential diagnosis of acquired demyelinating syndromes (ADS).Methods:Clinical course, MRI, MOG-abs, AQP4-abs, and CSF cells and oligoclonal bands (OCB) in children with ADS a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd87c2399eed1d13af6501873fac876
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/89846